Analytical Data
-
Gene name
MGC12981
- Application
-
Alternative Names
Coiled-coil domain containing 115
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
B8ZZ99
-
Expression Region
1-132 aa
-
AA Sequence
MGAKSVGPLQYASHMEPQVCLHASEAQEGLQKFKVVRAGVHAPEEVGPREAGLRRRKGPTKTPEPESSEAPQDPLNWFGILVPHSLRQAQASFRDGLQLAADIASLQNRIDWGRSQLRGLQEKLKQLEPGAA
-
Molecular Weight
40.26 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MGC12981 is a recombinant protein that has garnered significant attention in the field of molecular biology and biotechnology due to its potential applications in therapeutic and diagnostic contexts. Initially identified through various genomic studies, MGC12981 is believed to play a crucial role in cellular processes, though its specific biological functions are not fully understood. Research has indicated that this protein may be implicated in key pathways related to cell proliferation and differentiation, making it a candidate for further investigation in cancer research and regenerative medicine. The production of MGC12981 as a recombinant protein allows for detailed studies of its structure and function, facilitating the development of targeted therapies and novel diagnostic tools. Understanding the properties of MGC12981 could shed light on its potential role in disease mechanisms and its utility as a biomarker or therapeutic agent. Furthermore, advances in protein engineering techniques enable the modification and optimization of MGC12981, which could enhance its stability and efficacy in clinical applications. Therefore, ongoing research into MGC12981 not only contributes to our understanding of fundamental biological processes but also holds promise for innovative solutions in medical science.
